[작성자:] cms3billion
-
Run for Rare: 3billion’s In-House Marathon Challenge for Rare Disease Day 2025
In honor of Rare Disease Day 2025, 3billion is proud to launch the “Run for Rare” marathon challenge—a company-wide initiative aimed at raising awareness about rare diseases and supporting patients in their diagnostic journeys. This challenge symbolizes our commitment to improving access to genetic testing and underscores the urgency of accelerating diagnosis for individuals facing rare conditions. Why…
-
3billion and AstraZeneca Korea Partner to Revolutionize aHUS Genetic Diagnosis
3billion and AstraZeneca Korea have announced a strategic partnership to expedite the genetic diagnosis of atypical hemolytic uremic syndrome (aHUS), a rare and life-threatening disease. The collaboration aims to reduce the diagnostic timeline from several weeks to just two weeks, ensuring that patients receive timely and effective treatment. Addressing a Critical Gap in aHUS Diagnosis…
-
How to Reduce Risks of Inherited Disorders
Inherited disorders are genetic conditions passed down from parents to their children. These conditions result from mutations in genes and can lead to serious health complications. While we cannot change our genetic makeup, advancements in genomic medicine offer ways to reduce risks through early detection, informed decision-making, and precision-based interventions. Understanding Inherited Disorders Inherited disorders…
-
How to Choose the Best Genetic Testing Service: A Complete Buyer’s Guide
When choosing a genetic testing service for inherited diseases, it’s crucial to consider several key factors to ensure accuracy, reliability, and meaningful results. Questions to Ask Before Choosing a Genetic Test What Conditions Does This Test Screen For? Before choosing a genetic test, determine which inherited diseases it covers. Some tests focus on a single…